Publicaciones en las que colabora con María Ester González Sánchez (11)

2024

  1. Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 87-98

  2. Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury

    International Journal of Biological Sciences, Vol. 20, Núm. 7, pp. 2339-2355

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma

    Liver International, Vol. 43, Núm. 12, pp. 2776-2793

2022

  1. Genetic alterations shaping tumor response to anti-EGFR therapies

    Drug Resistance Updates, Vol. 64

2021

  1. Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 4

  2. The tgf-β pathway: A pharmacological target in hepatocellular carcinoma?

    Cancers, Vol. 13, Núm. 13

  3. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling

    Hepatology, Vol. 74, Núm. 6, pp. 3194-3212

2020

  1. Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma

    Cancers, Vol. 12, Núm. 5

2015

  1. E-cadherin, guardian of liver physiology

    Clinics and Research in Hepatology and Gastroenterology, Vol. 39, Núm. 1, pp. 3-6

2012

  1. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins

    Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576